0001438133-23-000050.txt : 20230307
0001438133-23-000050.hdr.sgml : 20230307
20230307184127
ACCESSION NUMBER: 0001438133-23-000050
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230303
FILED AS OF DATE: 20230307
DATE AS OF CHANGE: 20230307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BERGER DAVID B
CENTRAL INDEX KEY: 0001422126
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36189
FILM NUMBER: 23714311
MAIL ADDRESS:
STREET 1: 11045 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC
CENTRAL INDEX KEY: 0001438133
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204327508
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11075 ROSELLE STREET
CITY: San Diego
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-366-6900
MAIL ADDRESS:
STREET 1: 11075 ROSELLE STREET
CITY: San Diego
STATE: CA
ZIP: 92121
4
1
wf-form4_167823247447992.xml
FORM 4
X0306
4
2023-03-03
0
0001438133
TANDEM DIABETES CARE INC
TNDM
0001422126
BERGER DAVID B
C/O TANDEM DIABETES CARE, INC.
11075 ROSELLE STREET
SAN DIEGO
CA
92121
0
1
0
0
EVP & Chief Operating Officer
Common Stock
2023-03-03
4
M
0
10000
18.86
A
13365
D
Common Stock
2023-03-03
4
S
0
10000
41.1884
D
3365
D
Common Stock
242
I
Berger Family Trust
Stock Option
18.86
2023-03-03
4
M
0
10000
18.86
A
Common Stock
10000.0
0
D
The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $41.16 to $41.24. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The securities are held by the Berger Family Trust dated April 16, 2008.
The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").
The expiration date for these options is 10 years from the date of grant.
/s/ Rachel Malina, Attorney-in-Fact for David B. Berger
2023-03-07